245 related articles for article (PubMed ID: 30307604)
1. IL4-10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10.
Steen-Louws C; Hartgring SAY; Popov-Celeketic J; Lopes AP; de Smet MBM; Eijkelkamp N; Lafeber FPJG; Hack CE; van Roon JAG
Clin Exp Immunol; 2019 Jan; 195(1):1-9. PubMed ID: 30307604
[TBL] [Abstract][Full Text] [Related]
2. IL4-10 Fusion Protein Is a Novel Drug to Treat Persistent Inflammatory Pain.
Eijkelkamp N; Steen-Louws C; Hartgring SA; Willemen HL; Prado J; Lafeber FP; Heijnen CJ; Hack CE; van Roon JA; Kavelaars A
J Neurosci; 2016 Jul; 36(28):7353-63. PubMed ID: 27413147
[TBL] [Abstract][Full Text] [Related]
3. IL4-10 fusion protein has chondroprotective, anti-inflammatory and potentially analgesic effects in the treatment of osteoarthritis.
Steen-Louws C; Popov-Celeketic J; Mastbergen SC; Coeleveld K; Hack CE; Eijkelkamp N; Tryfonidou M; Spruijt S; van Roon JAG; Lafeber FPJG
Osteoarthritis Cartilage; 2018 Aug; 26(8):1127-1135. PubMed ID: 29775732
[TBL] [Abstract][Full Text] [Related]
4. Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study.
van Helvoort EM; Popov-Celeketic J; Eijkelkamp N; Coeleveld K; Tryfonidou MA; Wijne CD; Hack CE; Lafeber FPJG; Mastbergen SC
PLoS One; 2019; 14(7):e0219587. PubMed ID: 31295306
[TBL] [Abstract][Full Text] [Related]
5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
6. IL-1 receptor antagonist (IL-1Ra)-Fc ameliorate autoimmune arthritis by regulation of the Th17 cells/Treg balance and arthrogenic cytokine activation.
Lee SY; Min HK; Lee SH; Shin HJ; Lee WY; Cho YG; Kwok SK; Ju JH; Cho ML; Park SH
Immunol Lett; 2016 Apr; 172():56-66. PubMed ID: 26903194
[TBL] [Abstract][Full Text] [Related]
7. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
8. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.
Schuerwegh AJ; Van Offel JF; Stevens WJ; Bridts CH; De Clerck LS
Rheumatology (Oxford); 2003 Apr; 42(4):541-8. PubMed ID: 12649401
[TBL] [Abstract][Full Text] [Related]
9. The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta.
Yin Z; Siegert S; Neure L; Grolms M; Liu L; Eggens U; Radbruch A; Braun J; Sieper J
Rheumatology (Oxford); 1999 Nov; 38(11):1058-67. PubMed ID: 10556256
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.
Hart PH; Ahern MJ; Smith MD; Finlay-Jones JJ
Immunology; 1995 Apr; 84(4):536-42. PubMed ID: 7790026
[TBL] [Abstract][Full Text] [Related]
11. A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis.
Liu X; Zhou H; Huang X; Cui J; Long T; Xu Y; Liu H; Yu R; Zhao R; Luo G; Huang A; Liang JG; Liang P
J Immunol; 2016 Oct; 197(8):3029-3037. PubMed ID: 27619991
[TBL] [Abstract][Full Text] [Related]
12. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
Sebbag M; Parry SL; Brennan FM; Feldmann M
Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of an enhanced human serum amyloid A (SAA2) promoter-regulated soluble TNF receptor fusion protein for anti-inflammatory gene therapy.
Rygg M; Uhlar CM; Thorn C; Jensen LE; Gaughan DJ; Varley AW; Munford RS; Göke R; Chen Y; Whitehead AS
Scand J Immunol; 2001 Jun; 53(6):588-95. PubMed ID: 11422907
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo.
Jorgensen C; Apparailly F; Couret I; Canovas F; Jacquet C; Sany J
Immunology; 1998 Apr; 93(4):518-23. PubMed ID: 9659224
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.
Olas K; Butterweck H; Teschner W; Schwarz HP; Reipert B
Clin Exp Immunol; 2005 Jun; 140(3):478-90. PubMed ID: 15932509
[TBL] [Abstract][Full Text] [Related]
16. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
[TBL] [Abstract][Full Text] [Related]
17. Anti-arthritogenic effect of Saponin-1 by alteration of Th1/Th2 cytokine paradigm in arthritic mice.
Pandey A; Rizvi M; Shah BA; Bani S
Cytokine; 2016 Mar; 79():103-13. PubMed ID: 26799426
[TBL] [Abstract][Full Text] [Related]
18. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.
Scuderi F; Convertino R; Molino N; Provenzano C; Marino M; Zoli A; Bartoccioni E
Autoimmunity; 2003 Mar; 36(2):71-7. PubMed ID: 12820688
[TBL] [Abstract][Full Text] [Related]
19. Effects of pro- and anti-inflammatory cytokines and nitric oxide donors on hyaluronic acid synthesis by synovial cells from patients with rheumatoid arthritis.
Chenevier-Gobeaux C; Morin-Robinet S; Lemarechal H; Poiraudeau S; Ekindjian JC; Borderie D
Clin Sci (Lond); 2004 Sep; 107(3):291-6. PubMed ID: 15149282
[TBL] [Abstract][Full Text] [Related]
20. Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA).
Ruschpler P; Stiehl P
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):285-93. PubMed ID: 12030433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
